The medical devices maker anticipates introducing the product in Europe and other international markets in the first half of 2012.
The new device features a rotating diamond-coated tip designed to break through occluded peripheral arteries and facilitate the placement of conventional guidewires for treatment of peripheral lesions. It requires no capital equipment and is available with an optional extension wire to facilitate catheter exchange and increase the working length beyond 300 cm.
Jeff Mirviss, president of the peripheral interventions division at Boston Scientific, said: “The TruePath device is another example of innovation in our priority growth area targeting peripheral vascular disease, where a significant number of patients remain undiagnosed or untreated.
“This innovative crossing device further expands our growing peripheral interventions portfolio and offers physicians an option to treat patients with challenging lesions in the lower extremities who may have otherwise faced amputation. Addressing this growing health problem through the use of less-invasive devices could greatly improve patient care and ultimately save limbs.”
JA Mustapha, director of endovascular intervention at Metro Health Hospital in Wyoming, said: “CTOs are very challenging, requiring additional time, resources and patient exposure to imaging contrast and radiation. The TruePath device is an exciting new technology that allows me to effectively penetrate these difficult blockages with greater speed and ease, allowing access to untreated lesions and helping to improve overall patient outcomes.”
Have your say and discuss with your peers on the InfoGrok community.
Participate by posting your comments now.